Scott Bizily
Vermögen: 85 394 $ am 31.05.2026
Vermögen: 85 394 $ am 31.05.2026
Scott P.
Bizily is Secretary, Chief Compliance & Legal Officer at 4D Molecular Therapeutics, Inc. since 2024.
Dr. Bizily was General Counsel at Synthego Corp.
from 2019 to 2021.
Dr. Bizily was Director-Corporate Counsel at BioMarin Pharmaceutical, Inc. Dr. Bizily worked at Princeton University from 1991 to 1994.
Dr. Bizily earned a doctorate from the University of Georgia in 2001 and a graduate degree from the University of Pennsylvania in 2005.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 30.06.2026 | 8 617 ( 0,02 % ) | 85 394 $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| 4D MOLECULAR THERAPEUTICS, INC. | Compliance Officer | 01.12.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Develops CRISPR solutions | General Counsel | 01.09.2021 |
| BIOMARIN PHARMACEUTICAL INC. | General Counsel | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
BioMarin Pharmaceutical, Inc.
BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Synthego Corp.
Synthego Corp. BiotechnologyHealth Technology Develops CRISPR solutions | Health Technology |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
4D Molecular Therapeutics, Inc.
4D Molecular Therapeutics, Inc. BiotechnologyHealth Technology Designs, develops and commercializes transformative gene therapeutic products for serious unmet medical conditions | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen